A context-aware analytical framework for DNA methylation biomarker discovery

A gene-centered framework reveals context-dependent shifts in DNA methylation biomarker candidates across multiple cancers.

• Why it matters: Understanding how methylation signals vary across different biological backgrounds is crucial for developing reliable biomarkers. This work addresses the gap in considering context when prioritizing methylation changes for clinical use.
• What they did: The authors integrated methylation contrast, intersample variability, reference layers, and sequence features to prioritize genomic regions, applying this approach to colorectal, hepatocellular, and lung cancers, and validated selected regions with PCR assays in independent cohorts.
• The result: The framework enables a context-aware pathway from genome-scale methylation data to experimentally addressable biomarker targets, highlighting the importance of biological background in candidate selection.